多可萨赫萨酸通过抑制内分泌类系统来调节非酒精性脂肪性肝病
Yan-Fang Chen1,2, Ze-Kai Fan1,2, Yin-Peng Wang1,2
1Institute of Nutrition & Health, Qingdao University, Qingdao, 266071, China.
Molecular nutrition & food research
|March 2, 2024
概括
多可萨赫萨酸 (DHA) 通过抑制内分泌系统来改善非酒精性脂肪性肝病 (NAFLD). 这项研究发现,DHA可以降低与NAFLD进展相关的特定脂质标记物.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 脂质代谢 脂质代谢是什么
背景情况:
- 内体cannabinoid系统 (ECS) 信号传递对于能量恒温至关重要,并且与非酒精性脂肪肝疾病 (NAFLD) 有关.
- 多可萨赫萨酸 (DHA) 在改善NAFLD方面显示出比eicosapentaenoic acid (EPA) 更大的疗效,但机制尚不清楚.
研究的目的:
- 研究DHA是否通过调节ECS来缓解NAFLD.
- 阐明DHA影响NAFLD的特定途径.
主要方法:
- 一项病例控制研究测量了60名NAFLD患者和60名健康对照者的血清内可纳比诺इड配体.
- 使用高脂肪/高胆固醇饮食 (HFD) 建立了NAFLD的小鼠模型,随后给予DHA或EPA.
- 进行了血清配体,肝脏大麻素受体1表达,脂管学和胺分析.
主要成果:
- 与对照组相比,患有NAFLD的个体表现出较高的血清胺 (AEA) 和2-阿拉基多尼尔甘油 (2-AG).
- 在NAFLD小鼠模型中,DHA的使用显著降低了血清2-AG和脂肪细胞大麻素受体1的表达.
- DHA治疗导致肝脏C16:0-胺减少,脂肪酸合成减少,脂肪酸β-氧化增加.
结论:
- DHA通过抑制内分泌系统来改善NAFLD.
- 这些发现突出了DHA在NAFLD治疗效果的新机制.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
277
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
277
Overview of Lipid Metabolism
1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K


